B+
Bull case
25%
Probability
Target price
$18.50
+19.6% vs current
OSPN
OneSpanANasdaq / Software & Services
Last Price
At close
2026-07-18
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$16.25
+5.0% vs current
B-
Bear case
25%
Probability
Target price
$12.75
-17.6% vs current
AI sentiment snapshot
Latest data as of 2026-07-18
Recent news sentiment (30D)
+0.6
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+48.9
Score
AI commentary
News tone is mildly constructive around ARR, digital credentials, commercial investment, and the scheduled Q2 report, but coverage is low and verified analyst reaction is unavailable. Social, options, short-interest, and employee-sentiment measures are not present in the evidence packet. The setup remains monitoring-positive rather than high-conviction.
RankAlpha Sentiment Codex - 2026-07-18
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-04eventQ2 results are the next ARR and execution testMedium impact
OneSpan is scheduled to report Q2 2026 results on August 4, 2026. Q1 showed revenue growth, stronger subscription revenue and ARR, and raised full-year ARR guidance, but operating income and adjusted EBITDA declined year over year. Q2 must confirm ARR momentum without further profitability deterioration [#PR-EARNINGS-2026-07-09] [#PR-EARNINGS-2026-05-01] [#SEC-8K-2026-04-30].
2026-08-15catalystDigital credentials adoption checkpointMedium impact
OneSpan launched early access for digital credentials in June and expected general availability in the following weeks. The opportunity is meaningful only if early access converts into visible pipeline, customers, or revenue rather than remaining a product announcement.
2026-10-31catalystBuild38 integration and commercial expansionMedium impact
The Build38 acquisition and recent go-to-market leadership additions could improve cybersecurity growth, channel reach, and cross-sell over time. Evidence supports an execution-monitoring thesis, not yet a proven growth inflection.
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology